Evogene Ltd.

NASDAQ: EVGN · Real-Time Price · USD
1.33
-0.03 (-2.21%)
At close: Aug 15, 2025, 1:26 PM

Evogene Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
15.3M 20.77M 28.98M 32.33M
Short-Term Investments
10K 10.29M 6.38M 21.54M
Long-Term Investments
82K n/a n/a n/a
Other Long-Term Assets
12K 28K 74K 25K
Receivables
1.49M 671K 803K 1.17M
Inventory
1.82M 76K 566K 92K
Other Current Assets
1.3M 1.75M 32K 8K
Total Current Assets
21.59M 34.47M 37.75M 56.89M
Property-Plant & Equipment
4.25M 3.44M 4.07M 4.18M
Goodwill & Intangibles
12.2M 13.17M 14.14M 15.21M
Total Long-Term Assets
18.27M 16.63M 18.38M 19.41M
Total Assets
39.86M 51.1M 56.13M 76.3M
Account Payables
1.23M 1.78M 1.04M 1.46M
Deferred Revenue
683K 362K 101K 264K
Short-Term Debt
10.37M n/a 884K n/a
Other Current Liabilities
2.88M 1.41M 1.62M 1.61M
Total Current Liabilities
18.7M 6.94M 5.63M 6.88M
Long-Term Debt
n/a 10.37M 10.11M n/a
Other Long-Term Liabilities
90K 393K n/a n/a
Total Long-Term Liabilities
6.33M 15.47M 15.71M 6M
Total Liabilities
25.03M 22.42M 21.34M 12.88M
Total Debt
12.87M 11.51M 11.93M 2.67M
Common Stock
363K 286K 235K 234K
Retained Earnings
-274.07M -257.59M -233.71M -207.07M
Comprehensive Income
n/a n/a 261.4M 260.49M
Shareholders Equity
-1.45M 12.05M 27.93M 54.03M
Total Investments
92K 10.29M 6.38M 21.54M